Citation: Alm. Swislocki et D. Siegel, Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes, AM J M CARE, 7(3), 2001, pp. 283-295
Authors:
Siegel, D
Lopez, J
Meier, J
Cunningham, F
Citation: D. Siegel et al., Changes in the pharmacologic treatment of hypertension in the department of veterans affairs 1997-1999: Decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics, AM J HYPERT, 14(9), 2001, pp. 957-962
Citation: D. Siegel et T. Neiders, Vertebral artery dissection and pontine infarct after chiropractic manipulation, AM J EMER M, 19(2), 2001, pp. 171-172
Authors:
Wilson, MW
Schelonka, LP
Siegel, D
Meininger, A
Ross, D
Citation: Mw. Wilson et al., Immunohistochemical localization of NAD(P)H : quinone oxidoreductase in conjunctival melanomas and primary acquired melanosis, CURR EYE R, 22(5), 2001, pp. 348-352
Authors:
Siegel, D
Anwar, A
Winski, SL
Kepa, JK
Zolman, KL
Ross, D
Citation: D. Siegel et al., Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H : Quinone oxidoreductase 1, MOLEC PHARM, 59(2), 2001, pp. 263-268
Authors:
Desikan, KR
Tricot, G
Munshi, NC
Anaissie, E
Spoon, D
Fassas, A
Toor, A
Zangari, M
Badros, A
Morris, C
Vesole, DH
Siegel, D
Jagannath, S
Barlogie, B
Citation: Kr. Desikan et al., Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone, BR J HAEM, 112(1), 2001, pp. 242-247
Authors:
van Muiswinkel, FL
Riemers, FM
Peters, GJ
LaFleur, MVM
Siegel, D
Jongenelen, CAM
Drukarch, B
Citation: Fl. Van Muiswinkel et al., L-Dopa stimulates expression of the antioxidant enzyme NAD(P)H : quinone oxidoreductase (NQO) in cultured astroglial cells, FREE RAD B, 29(5), 2000, pp. 442-453
Authors:
Desikan, KR
Tricot, G
Dhodapkar, M
Fassas, A
Siegel, D
Vesole, DH
Jagannath, S
Singhal, S
Mehta, J
Spoon, D
Anaissie, E
Barlogie, B
Munshi, N
Citation: Kr. Desikan et al., Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone, BONE MAR TR, 25(5), 2000, pp. 483-487
Authors:
Schelonka, LP
Siegel, D
Wilson, MW
Meininger, A
Ross, D
Citation: Lp. Schelonka et al., Immunohistochemical localization of NQO1 in epithelial dysplasia and neoplasia and in donor eyes, INV OPHTH V, 41(7), 2000, pp. 1617-1622
Citation: A. Mcwilliams et D. Siegel, Corporate social responsibility and financial performance: Correlation or misspecification?, STRAT MANAG, 21(5), 2000, pp. 603-609
Authors:
Pink, JJ
Planchon, SM
Tagliarino, C
Varnes, ME
Siegel, D
Boothman, DA
Citation: Jj. Pink et al., NAD(P)H : quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity, J BIOL CHEM, 275(8), 2000, pp. 5416-5424
Authors:
Ross, D
Kepa, JK
Winski, SL
Beall, HD
Anwar, A
Siegel, D
Citation: D. Ross et al., NAD(P)H : quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation,gene regulation and genetic polymorphisms, CHEM-BIO IN, 129(1-2), 2000, pp. 77-97
Authors:
Desikan, R
Barlogie, D
Sawyer, J
Ayers, D
Tricot, G
Badros, A
Zangari, M
Munshi, NC
Anaissle, E
Spoon, D
Siegel, D
Jagannath, S
Vesole, D
Epstein, J
Shaughnessy, J
Fassas, A
Lim, S
Roberson, P
Crowley, J
Citation: R. Desikan et al., Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities, BLOOD, 95(12), 2000, pp. 4008-4010
Authors:
Siegel, D
McGuinness, SM
Winski, SL
Ross, D
Citation: D. Siegel et al., Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H :quinone oxidoreductase 2 (vol 9, pg 113, 1999), PHARMACOGEN, 9(3), 1999, pp. 419-419